PT-141 10mg

Description

PT-141 10 mg is a synthetic peptide also known as bremelanotide, an analogue of the endogenous hormone α-MSH (alpha-melanocyte-stimulating hormone) belonging to the melanocortin peptide group. This compound was initially developed as a metabolite of the peptide Melanotan II and is studied primarily for its effects on the nervous system and sexual function.

Chemical characteristics

PT-141 is a cyclic heptapeptide (a short chain of seven amino acids) designed as a melanocortin receptor agonist. It acts mainly by activating MC3R and MC4R receptors in the central nervous system — receptors associated with the regulation of sexual desire, motivation and reward.

Mechanism of action

PT-141 acts primarily on melanocortin receptors in the brain, which distinguishes it from conventional erectile dysfunction drugs that act on the vascular system. By activating MC3R and MC4R, it affects the centres responsible for desire (sexual excitement) and arousal (sexual response), rather than directly affecting blood flow in the genital organs.

Effects observed in studies

Data from experimental studies and preliminary studies in human and animal models indicate that PT-141 may:

• increase libido and sexual arousal,
• influence sexual responses by modulating central neural pathways,
• be studied in the context of sexual dysfunction, including low sexual desire and erectile dysfunction in clinical and preclinical models.

PT-141 attracted particular attention when studies demonstrated its effect on improving sexual responses independently of vascular mechanisms.

Product specifications

• Name: PT-141 (bremelanotide)
• Content: 10 mg
• Compound type: synthetic peptide (melanocortin receptor agonist)
• Mechanism of action: activation of MC3R and MC4R receptors in the central nervous system

Product intended exclusively for laboratory research use.